Clinical Trials Directory

Trials / Suspended

SuspendedNCT03362424

Mesenchymal Stem Cells in Rotator Cuff Repair

Mesenchymal Stem Cells in Rotator Cuff Repair - a Randomized Prospective Study

Status
Suspended
Phase
Phase 2
Study type
Interventional
Enrollment
44 (estimated)
Sponsor
University of Sao Paulo · Academic / Other
Sex
All
Age
35 Years
Healthy volunteers
Accepted

Summary

Randomized clinical study involving 44 patients, evaluating the effect of mesenchymal cells on rotator cuff repair. The primary outcome will be post-operative MRI tendon integrity and secondary outcomes clinical assessment by the UCLA and American Shoulder and Elbow Surgeons (ASES) scales and pain by visual analog scale (VAS).

Detailed description

Rotator cuff tendinopathy is the main cause of shoulder pain and tear of these tendons affects 20% of the population. Although arthroscopic repair leads to satisfactory clinical results, the retear rates varies from 4 to 94%. The main cause of failure after rotator cuff repair is not related to the material used, but to the tissue deficiency and the healing process between the tendon and the bone. After the intervention, the rotator cuff does not restore its original histological characteristics and its fixation occurs through scar tissue with lower biomechanical resistance. There are few clinical studies on the use of mesenchymal cells in rotator cuff repair,, with good results. The investigators will perform a randomized clinical study involving 44 patients, evaluating the effect of mesenchymal cells on rotator cuff repair. The primary outcome will be post-operative MRI tendon integrity and secondary outcomes clinical assessment by the UCLA and American Shoulder and Elbow Surgeons (ASES) scales and pain by visual analog scale (VAS).

Conditions

Interventions

TypeNameDescription
BIOLOGICALMesenchymal stem cellMesenchymal stem cells applies at the end of rotator cuff repair in de active group
PROCEDURERotator cuff repairRotator cuff repair

Timeline

Start date
2020-11-01
Primary completion
2023-12-01
Completion
2023-12-01
First posted
2017-12-05
Last updated
2022-10-19

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT03362424. Inclusion in this directory is not an endorsement.